India to Thailand: Docetaxel Export Trade Route
India has recorded 36 verified shipments of Docetaxel exported to Thailand, representing a combined trade value of $1.1M USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $31.6K USD. The leading Indian exporter is FRESENIUS KABI ONCOLOGY LIMITED, which accounts for 70% of total export value with 18 shipments worth $790.8K USD. On the buying side, FRESENIUS KABI (THAILAND) LTD is the largest importer in Thailand with $235.9K USD in purchases. The top 3 suppliers — FRESENIUS KABI ONCOLOGY LIMITED, FRESENIUS KABI ONCOLOGY LIMITED , GLS PHARMA LIMITED — together control 99% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Thailand Docetaxel corridor is one of India's established pharmaceutical export routes, with 36 shipments documented worth a combined $1.1M USD. The route is dominated by FRESENIUS KABI ONCOLOGY LIMITED, which alone accounts for roughly 70% of all export value, reflecting the consolidated nature of India's docetaxel manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $31.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with docetaxel's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 18.1%, placing it at rank #3 among India's top docetaxel export destinations globally.
On the import side, key buyers of Indian docetaxel in Thailand include FRESENIUS KABI (THAILAND) LTD, FRESENIUS KABI (THAILAND) LTD , FRESENIUS KABI(THAILAND)LIMITED and 12 others. FRESENIUS KABI (THAILAND) LTD is the single largest importer with 5 shipments valued at $235.9K USD.
Route Characteristics
- Average transit26 days
- Peak seasonQ2
- Primary modeSea freight
- Top portDELHI AIR
Market Position
- Global rank#3
- Annual growth+18.1%
- Demand growth+15.6%
- Regulatory ease83/100
Top 10 Indian Docetaxel Exporters to Thailand
Showing top 10 of 7 Indian suppliers exporting Docetaxel to Thailand, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | FRESENIUS KABI ONCOLOGY LIMITED Avg $43.9K per shipment | 18 | $790.8K | 69.5% |
| 2 | FRESENIUS KABI ONCOLOGY LIMITED Avg $41.8K per shipment | 8 | $334.3K | 29.4% |
| 3 | GLS PHARMA LIMITED Avg $1.8K per shipment | 3 | $5.3K | 0.5% |
| 4 | ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED Avg $4.6K per shipment | 1 | $4.6K | 0.4% |
| 5 | VIOTONIC MEDICATION Avg $820 per shipment | 2 | $1.6K | 0.1% |
| 6 | MEDYRA PHARMACEUTICAL Avg $469 per shipment | 2 | $938 | 0.1% |
| 7 | MBA PHARMACEUTICALS PRIVATE LIMITED Avg $101 per shipment | 2 | $202 | 0.0% |
This table shows the top 10 of 7 Indian companies exporting docetaxel to Thailand, ranked by total trade value. The listed exporters are: FRESENIUS KABI ONCOLOGY LIMITED, FRESENIUS KABI ONCOLOGY LIMITED , GLS PHARMA LIMITED, ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED, VIOTONIC MEDICATION, MEDYRA PHARMACEUTICAL, MBA PHARMACEUTICALS PRIVATE LIMITED. FRESENIUS KABI ONCOLOGY LIMITED is the dominant supplier with 18 shipments worth $790.8K USD, giving it a 70% market share. The top 3 suppliers together account for 99% of the total trade value on this route.
Top 10 Docetaxel Importers in Thailand
Showing top 10 of 15 known buyers in Thailand receiving Docetaxel shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian docetaxel in Thailand include FRESENIUS KABI (THAILAND) LTD, FRESENIUS KABI (THAILAND) LTD , FRESENIUS KABI(THAILAND)LIMITED, FRESENIUS KABI THAILAND LTD, FRESENIUS KABI (THAILAND) LIMITED, among 15 total buyers. The largest importer is FRESENIUS KABI (THAILAND) LTD, accounting for $235.9K USD across 5 shipments — representing 21% of all docetaxel imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | FRESENIUS KABI (THAILAND) LTD | 5 | $235.9K | 20.7% |
| 2 | FRESENIUS KABI (THAILAND) LTD | 4 | $204.9K | 18.0% |
| 3 | FRESENIUS KABI(THAILAND)LIMITED | 2 | $199.9K | 17.6% |
| 4 | FRESENIUS KABI THAILAND LTD | 6 | $181.1K | 15.9% |
| 5 | FRESENIUS KABI (THAILAND) LIMITED | 2 | $105.7K | 9.3% |
| 6 | FRESENIUS KABI(THAILAND)LTD | 3 | $86.3K | 7.6% |
| 7 | FRESENIUS KABI (THAILAND) LTD. | 1 | $43.0K | 3.8% |
| 8 | FRESENIUS KABI THAILAND LIMITED | 2 | $36.5K | 3.2% |
| 9 | FRESENIUS KABI (THAILAND) LTD., | 1 | $31.6K | 2.8% |
| 10 | PFIZER SERVICE COMPANY BV | 1 | $4.6K | 0.4% |
Showing top 10 of 15 Docetaxel importers in Thailand on this route.
Top 10 Docetaxel Formulations Imported by Thailand
Showing top 10 of 33 product formulations shipped on the India to Thailand Docetaxel route, ranked by trade value
Thailand imports a wide range of docetaxel formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — DAXOTEL (DOCETAXEL ) INJ. 80MG/4ML VIAL — accounts for $208.5K USD across 3 shipments. There are 33 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DAXOTEL (DOCETAXEL ) INJ. 80MG/4ML VIAL | 3 | $208.5K | 18.3% |
| 2 | DAXOTEL(DOCETAXEL)INJ.80MG/4MLVIAL B NO-NO-87240157ABMFG.DT. 04/24 EXP.DT. 03/2026 | 1 | $108.3K | 9.5% |
| 3 | DAXOTEL (DOCETAXEL) USP INJ. 20MG/1ML VIAL BNO.87230482AJ, MFG. DT. 11/2023, EXP. DT. 10/2025 | 1 | $105.5K | 9.3% |
| 4 | DAXOTEL(DOCETAXEL)INJ.80MG/4MLVAIL B NO-87240161BAMFG.DT.05/24 EXP.DT. 04/2026 | 1 | $91.6K | 8.1% |
| 5 | DAXOTEL (DOCETAXEL ) INJ. 80MG/4ML VIALBATCH NO. 87240023BC MFG. DT. 01/2024EXP. DT. 12/2025NOS | 1 | $70.9K | 6.2% |
| 6 | DAXOTEL DOCETAXEL INJ 80MG 4ML VIALBATCH NO 87250114BA MFG DT 04 2025 EXP DT 03 2027 6342 VIALS | 1 | $61.3K | 5.4% |
| 7 | DAXOTEL(DOCETAXEL)INJ.80MG/4ML VIAL | 1 | $50.6K | 4.4% |
| 8 | DAXOTEL (DOCETAXEL) USP INJ. 80MG/4ML VIAL BNO.87230482BA, MFG. DT. 11/2023, EXP. DT. 10/2025 | 1 | $50.3K | 4.4% |
| 9 | DAXOTEL DOCETAXEL INJ 20MG 1ML VIAL BATCH NO 87230066AH MFG DT 02 2023 EXP DT 01 2025 | 1 | $47.4K | 4.2% |
| 10 | DAXOTEL (DOCETAXEL) INJ. 20MG/1ML VIAL,BATCH NO. 87240249CA, MFG. DT. 06/2024,EXP. DT. 05/2026 | 1 | $46.1K | 4.0% |
Showing top 10 of 33 Docetaxel formulations imported by Thailand on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 79%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR handles the highest volume with 13 shipments. Transit time averages 26 days by sea.
Market Dynamics
India's docetaxel exports to Thailand are driven primarily by a handful of large-scale manufacturers. FRESENIUS KABI ONCOLOGY LIMITED with 18 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Thailand benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — FRESENIUS KABI ONCOLOGY LIMITED, FRESENIUS KABI ONCOLOGY LIMITED , GLS PHARMA LIMITED — together account for 99% of total trade value on this route. The average shipment value of $31.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as daxotel(docetaxel)inj.80mg/4mlvial b no-no-87240157abmfg.dt. 04/24 exp.dt. 03/2026 and daxotel (docetaxel) usp inj. 20mg/1ml vial bno.87230482aj, mfg. dt. 11/2023, exp. dt. 10/2025, suggesting that buyers in Thailand tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, FRESENIUS KABI (THAILAND) LTD is the largest importer with 5 shipments worth $235.9K USD — representing 21% of all docetaxel imports from India on this route. A total of 15 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $1.1M
- Avg. Shipment
- $31.6K
- Suppliers
- 7
- Buyers
- 15
- Transit (Sea)
- ~26 days
- Annual Growth
- +18.1%
Reverse Direction
Thailand → India — Docetaxel (Import)Other Docetaxel Routes
Unlock the Full India to Thailand Docetaxel Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 36 shipments on this route.
Frequently Asked Questions — India to Thailand Docetaxel Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Docetaxel to Thailand?
The leading Indian exporters of Docetaxel to Thailand are FRESENIUS KABI ONCOLOGY LIMITED, FRESENIUS KABI ONCOLOGY LIMITED , GLS PHARMA LIMITED. FRESENIUS KABI ONCOLOGY LIMITED holds the largest market share at approximately 70% of total trade value on this route.
Q What is the total value of Docetaxel exports from India to Thailand?
India exports Docetaxel to Thailand worth approximately $1.1M USD across 36 recorded shipments. The average value per shipment is $31.6K USD.
Q Which ports does India use to ship Docetaxel to Thailand?
The most active port of origin is DELHI AIR with 13 shipments. Indian exporters primarily use sea freight for this route, with 79% of shipments going by sea and 26% by air.
Q How long does shipping take from India to Thailand for Docetaxel?
The average transit time for Docetaxel shipments from India to Thailand is approximately 26 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Thailand Docetaxel trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 18.1% with demand growth tracking at 15.6%. The route is ranked #3 among India's top Docetaxel export destinations globally.
Q How many suppliers are active on the India to Thailand Docetaxel route?
There are currently 7 active Indian suppliers exporting Docetaxel to Thailand. The market is moderately concentrated with FRESENIUS KABI ONCOLOGY LIMITED accounting for 70% of total shipment value.
Q Who are the main importers of Docetaxel from India in Thailand?
The leading importers of Indian Docetaxel in Thailand include FRESENIUS KABI (THAILAND) LTD, FRESENIUS KABI (THAILAND) LTD , FRESENIUS KABI(THAILAND)LIMITED, FRESENIUS KABI THAILAND LTD, FRESENIUS KABI (THAILAND) LIMITED. FRESENIUS KABI (THAILAND) LTD is the largest buyer with 5 shipments worth $235.9K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Thailand export trade corridor identified from Indian Customs (DGFT) records for Docetaxel.
- 2.Supplier/Buyer Matching: 7 Indian exporters and 15 importers in Thailand matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 36 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
36 Verified Shipments
7 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists